Literature DB >> 34057150

Circular RNAs in cancer and diabetes.

Animesh Hatibaruah1, Mizanur Rahman, Satyakam Agarwala, Seram Anil Singh, Jisen Shi, Suruchi Gupta, Prosenjit Paul.   

Abstract

Circular RNAs (circRNAs) are a class of noncoding RNA molecules formed by the back splicing process. Compared to linear mRNA molecules they are more stable. CircRNA acts as miRNA sponges, regulates translation, epigenetic alterations, etc. However, the most significant aspect of circRNAs has been its role in regulating the hallmark of cancer and diabetes mellitus. Several circRNAs are extensively expressed in individuals with cancer and diabetics. Dysregulated expression of various circRNAs plays a crucial part in the development of type 2 diabetes mellitus. In the present review, we present the current understanding of cricRNAs biogenesis, regulatory mechanisms, reviews of recent findings and circRNA as potential biomarker.

Entities:  

Year:  2021        PMID: 34057150

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  3 in total

1.  Circ_0004712 Silencing Suppresses the Aggressive Changes of Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Targeting miR-633/TRAF6 Axis.

Authors:  Shihui Zhang; Zhizhong Shen; Gao Chao; Xiaolong Du; Wentao Zhang; Dan Jin; Yafei Liu
Journal:  Biochem Genet       Date:  2022-08-19       Impact factor: 2.220

Review 2.  Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives.

Authors:  Marianela Zambrano-Román; Jorge R Padilla-Gutiérrez; Yeminia Valle; José F Muñoz-Valle; Emmanuel Valdés-Alvarado
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

3.  CircRNF144B/miR-342-3p/FBXL11 axis reduced autophagy and promoted the progression of ovarian cancer by increasing the ubiquitination of Beclin-1.

Authors:  Wenting Song; Zhirui Zeng; Yilei Zhang; Haili Li; Huimin Cheng; Jun Wang; Fengrui Wu
Journal:  Cell Death Dis       Date:  2022-10-08       Impact factor: 9.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.